This observational study examines the use of glucose and lipid testing in Medicaid patients receiving antipsychotic therapy.
This randomized clinical trial reports that web-based cognitive behavioral therapy is associated with a reduced likelihood of suicidal ideation among medical interns.
Hatta et al examine whether ramelteon, a melatonin agonist, is effective for the prevention of delirium. See also the invited commentary by de Rooij et al.
Beardslee et al determine whether the positive effects of a group cognitive-behavioral prevention (CBP) program extended to longer-term (multiyear) follow-up.
This Special Communication examines the degree to which modern operationalized diagnostic criteria for schizophrenia reflect the main clinical features of the disorder as described historically by diagnostic experts.
This randomized clinical trial examines the effects of telephone-delivered cognitive-behavioral therapy compared with telephone-delivered nondirective supportive therapy in rural older adults with generalized anxiety disorder.
This Viewpoint addresses suicide prevention in the context of successful lay-led disease advocacy efforts.
This register-based cohort study in Denmark examines whether the incidence of and risk factors for depression differ between patients with stroke and a reference population without stroke and assesses the association of depression with mortality.
This pharmacoepidemiology study uses Medicare Part D data to describe the use of buprenorphine-naloxone in the United States in 2013.
This randomized trial compares the effects of metformin vs placebo on weight gain in children and adolescents with autism spectrum disorder taking atypical antipsychotics.
This randomized trial compares the efficacy of targeted complicated grief treatment, citalopram, both, or neither on the outcomes of patients with complicated grief.
This cohort study evaluates military sexual trauma as an independent risk factor for homelessness among male and female veterans.